MedPath

Impact of Early Versus Late Amniotomy on Labour Induction in Nulliparous Women After Vaginal Misoprostol

Not Applicable
Completed
Conditions
Labour Induction
Interventions
Registration Number
NCT04514770
Lead Sponsor
Menoufia University
Brief Summary

Investigation the effect of timing of amniotomy (early versus delayed) after vaginal misoprostol in induced labor.

Condition: induction of labour intervention: eary versus late amniotomy on labour induction after vaginal misoprostol Phase: Not applicable

Detailed Description

study type: randomized clinical trial actual enrollment: 140 allocation: Random intervention model: two groups assignment masking: open lebal primary purpose: induction of labour actual study start: May 3, 2019 Primary Completion: January 10, 2020 actual study completion date: March 20, 2020

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
140
Inclusion Criteria
  1. Pregnant women at 36 weeks gestation or more
  2. Nullipara
  3. singleton fetus
  4. cephalic presentation with common medical causes for labour induction e.g. intrauterine fetal growth restriction, post term pregnancy and preeclampsia.
Exclusion Criteria
  1. Macrocosmic babies with estimated fetal weight of more than 4000 gram
  2. Previous uterine scars
  3. Pre labor premature rupture of fetal membranes
  4. Polyhydramnios.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
early amniotomyMisoprostolGroup A: 1. Pregnant women had taken misoprostol (vagiprost vaginal tablet; Adwia Pharmaceutical Company) vaginally as 25 micro gram of misoprostol. It was repeated every 6 hours until three or more uterine contractions of 40 second duration occur over 10 minutes, or when reaching four doses maximum (i.e. 100 micro gram) is reached. 2. Early amniotomy was performed for the participant of the first group at 3 cementer cervical dilatation with Kocher's forceps provided the head is well fitted to the cervix.
Late amniotomyMisoprostolGroup B: 1. Pregnant women had taken misoprostol (vagiprost vaginal tablet; Adwia Pharmaceutical Company) vaginally as 25 micro gram of misoprostol. It was repeated every 6 hours until three or more uterine contractions of 40 second duration occur over 10 minutes, or when reaching four doses maximum (i.e. 100 micro gram) is reached. 2. late amniotomy was performed for the participant of the second group at 7 cementer cervical dilatation.
Primary Outcome Measures
NameTimeMethod
successful inductionimmediately after intervention

definition of successful induction is occurrence of vaginal delivery within 24 hours from the beginning of induction

induction-delivery intervalimmediately after intervention

duration of labor and amniotomy delivery interval

Secondary Outcome Measures
NameTimeMethod
Apgar scoreduring the intervention

Apgar score less than 7 at 1 and 5 minutes

misoprostol doses administeredduring the intervention

number of misoprostol doses administered

the need for augmentation of laborduring the intervention

the need for augmentation of labor by oxytocin and perinatal outcomes included cord prolapse and abnormal FHR changes during labor

intrapartum meconiumduring the intervention

intrapartum meconium passage

newborn admission in the neonatal intensive care unitimmediately after intervention

newborn admission in the neonatal intensive care unit (NICU).

Trial Locations

Locations (1)

Menoufia University hospital

🇪🇬

Shibīn Al Kawm, Menoufia, Egypt

© Copyright 2025. All Rights Reserved by MedPath